Insight Molecular Diagnostics, Inc. (IMDX)
5.15
+0.21
(+4.25%)
USD |
NASDAQ |
Dec 09, 16:00
5.21
+0.06
(+1.17%)
After-Hours: 20:00
Insight Molecular Diagnostics Total Liabilities (Quarterly): 53.13M for Sept. 30, 2025
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| FONAR Corp. | 56.96M |
| XWELL, Inc. | 18.68M |
| ProPhase Labs, Inc. | 58.84M |
| Veracyte, Inc. | 110.12M |
| Exagen, Inc. | 44.68M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 43.94M |
| Shareholders Equity (Quarterly) | -9.196M |
| Debt to Equity Ratio | -0.34 |
| Current Ratio | 2.792 |
| Net Debt Paydown Yield | 0.11% |